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Laser Therapy for Herpes Simplex
Recurrent herpes simplex of the lips (herpes labialis) is a common
and stubborn problem faced by dermatologists, many of whom
prefer not to chronically treat patients with antiviral agents such as
acyclovir due to the risk of emergence of viral resistance. Utilizing
a double-blind, placebo-controlled design, Andreas Schindl and
Reinhard Neumann from the University of Vienna demonstrated
(p. 223) a clear beneficial effect of low-intensity near-infrared laser
IL-15 in Hypertrophic Scars
Hypertrophic scars represent another clinical challenge for dermato-
logists. In addition to being unsightly, they are frequently uncomfort-
able, and distressingly persistent. Based on lesional histology, an
immunologic origin has long been suspected. In this report from the
University of Turin, Castagnoli et al. (p. 240) have identified IL-15 as
an excellent candidate for immunologic mediation of hypertrophic
scars. As shown by RT-PCR and immunostaining, IL-15 expression
A p53-like Protein in Ulcerative Stomatitis
While less common than herpes labialis or hypertrophic scars, ulcerative
stomatitis is yet another major clinical challenge for dermatologists. In
a detailed study employing immunologic and molecular biological
techniques, Lee et al. have demonstrated (p. 147) that a major
autoantigen in this disorder, which they have named CUSP, is a nuclear
protein encoded by a splice variant of the KET gene. Interestingly,
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light on recurrent herpes labialis: mean time to recurrence was
37.5 wk, versus 3 wk in controls. Lasers have exploded on the
dermatologic scene in recent years, mainly for cosmetic problems
of a surgical nature. While the mechanisms underlying this effect
remain to be discovered, the availability of an effective treatment
for a common problem portends that lasers will have a niche in
medical dermatology as well.
was substantially higher in active hypertrophic scars compared with
‘‘normal’’ scars and normal skin. Interestingly, regressing hypertrophic
scars demonstrated lower levels of and reduced T cell responsiveness
to IL-15. Unlike IL-2, IL-15 can be made by a variety of cells in
the wound environment, including keratinocytes, fibroblasts, and
macrophages. Based on this report, a study of wound healing in IL-15-
engineered mice would appear to be worthwhile.
KET is closely related to the tumor suppressor p53. While much
remains to be learned about the pathogenesis of ulcerative stomatitis,
these studies provide a key molecular target for further research. Also,
as the expression of CUSP is apparently confined to stratifying epithelia,
these studies raise the interesting question of the function of p53-like
proteins in the skin.
